John Peter McLaughlin's Net Worth

-$3.95 Million

Who is John Peter McLaughlin?

John Peter McLaughlin does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include SEATTLE GENETICS INC /WA, EYETECH PHARMACEUTICALS INC, ANESIVA, INC., Avalanche Biotechnologies, Inc., LENSAR, Inc., ROCKWELL MEDICAL, INC., and PDL BIOPHARMA, INC..

SEC CIK

John Peter McLaughlin's CIK is 0001277967

Past Insider Trading and Trends

2008 was John Peter McLaughlin's most active year for acquiring shares with 8 total transactions. John Peter McLaughlin's most active month to acquire stocks was the month of April. 2009 was John Peter McLaughlin's most active year for disposing of shares, totalling 4 transactions. John Peter McLaughlin's most active month to dispose stocks was the month of November. 2016 saw John Peter McLaughlin paying a total of $1,300,000.94 for 436,925 shares, this is the most they've acquired in one year. In 2005 John Peter McLaughlin cashed out on 150,000 shares for a total of $828,000.00, their largest year based on trade value.